Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
business
business sponsored company news
articles containing video clips
colloids
dosage forms
drug delivery devices
gels
histopathology
infectious causes of cancer
male genital neoplasia
neoplastic and hyperplastic prostate disorders
physical chemistry
prostate cancer
rtt
american medical association
anaerobic digestion
biodegradable waste management
biodegradation
companies based in minneapolis
companies established in 1895
companies listed on the new york stock exchange
illinois
investment banks
medical and health professional associations in chicago
minnesota
organizations established in 1847
supraorganizations
u.s. bancorp
What
announced
26
×
company
26
×
medical
26
×
press
26
×
release
today
technology
augmenix
develops
hydrogels
manufactures
organs
protect
radiotherapy
risk
sells
separate
absorbable
proprietary
announces
hydrogel
prostate
spaceoar
cancer
new
device
healthcare
million
annual
clinical
patients
trial
american
applications
completed
completes
conference
data
digital
financing
Language
Current search:
company
×
medical
×
announced
×
press
×
@venturebeat.com
6 years ago
AEGEA Medical Secures $40 Million Financing
@venturebeat.com
6 years ago
Augmenix to Present at the 36th Annual J.P. Morgan Healthcare Conference
@venturebeat.com
6 years ago
Bay Labs Completes $5.5 Million Series A Financing
@venturebeat.com
6 years ago
Augmenix® Announces Medicare Reimbursement Rates for the new CPT Code 55874, which will be used to bill SpaceOAR® Hydrogel, Effective January 2018
@venturebeat.com
6 years ago
CorInnova Awarded Seminal Patent for Minimally Invasively-Delivered Soft Robotic Heart Device to Support Heart Function
@venturebeat.com
6 years ago
Augmenix Announces Positive Clinical Trial Results Demonstrating Efficacy of SpaceOAR
@venturebeat.com
6 years ago
Augmenix to Unveil New Clinical Data on its Innovative Absorbable Hydrogel Technology at the 59th Annual Meeting of the American Society for Radiation Oncology
@venturebeat.com
6 years ago
Protembis Announces Successful First-in-Human Use of Its ProtEmbo® Cerebral Protection System in European Trial
@venturebeat.com
6 years ago
BrainScope Completes $16 Million Equity Fundraise
@venturebeat.com
6 years ago
NICE Announces Interventional Procedure Guidance Supporting Use of Hydrogel Spacer in Treatment of Prostate Cancer in the UK
@venturebeat.com
6 years ago
Kony Announces New EASE Application to Enhance Patient Experience and Satisfaction
@venturebeat.com
6 years ago
Augmenix, Inc. Announces Medicare Administrative Contractor Palmetto Coverage for SpaceOAR® Hydrogel
@venturebeat.com
6 years ago
Kony Helps Loop Rapidly Deliver New App That Connects Healthcare Providers With Patients and Their Family Members
@venturebeat.com
6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com
7 years ago
SpaceOAR® System Receives Shonin Approval in Japan
@venturebeat.com
7 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com
7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com
7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com
7 years ago
MyndBlue Elects Serial Medical/Digital Health Entrepreneur Nancy Briefs
@venturebeat.com
7 years ago
Augmenix To Present at the 35th Annual J.P. Morgan Healthcare Conference
@venturebeat.com
7 years ago
Augmenix to Present at the Annual Piper Jaffray Healthcare Conference on Wednesday, November 30
@venturebeat.com
7 years ago
Augmenix Announces New Category 1 CPT® Code from the American Medical Association for Periprostatic Implantation of Biodegradable Material
@venturebeat.com
7 years ago
HMicro Raises $10.2 Million in Series C Financing
@venturebeat.com
8 years ago
Portea Medical Announces US$37.5 Million Series B Funding Led by Accel
@venturebeat.com
8 years ago
Solace Therapeutics Completes Enrollment of the SUCCESS Clinical Trial for the Vesair® Bladder Control System for Stress Urinary Incontinence